Axsome Therapeutics (AXSM) Misses Q2 EPS by 36c, offers guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Nasdaq ends higher as AI heavyweights rebound ahead of midterm results
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
| (NASDAQ: AXSM) | Delayed: 139.61 +3.60 (2.65%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $136.01 | 52 Week High | $15.74 | |||
| Open | $136.88 | 52 Week Low | $5.37 | |||
| Day High | $145.50 | P/E | N/A | |||
| Day Low | $136.88 | EPS | $0.00 | |||
| Volume | 1,679,567 | |||||
